Talk:Biperiden

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine C‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Biperiden.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Availability

This drug is discontinued manufactured in the U.S. I take it. I need it! Please find out if someone knows about if it will ever be made again. Thank you — Preceding unsigned comment added by 75.161.136.190 (talk)

receptors binding

Potent, selective M1 receptor antagonist (Ki values are 0.48, 2.4, 3.9, 6.3 and 6.3 nM for M1, M4, M3, M2 and M5 receptors respectively). http://www.abcam.com/Biperiden-hydrochloride-ab141781.pdf https://www.scbt.com/scbt/product/biperiden-hydrochloride-1235-82-1 — Preceding unsigned comment added by 109.241.248.66 (talk) 15:30, 25 October 2014 (UTC)[reply]

Tourette syndrome treatment

Citation needed for biperiden's usage in treating Tourette syndrome.

All I could find was a case report of treating extrapyramidal symptoms caused by dopamine antagonists in a Tourette syndrome patient.

This one showed resolution of symptoms:

https://doi.org/10.1345/aph.1g331

I also found a case study of biperiden in a patient with schizophrenia and Tardive Tourette-like syndrome induced by antipsychotics, in which it appeared ineffective.

https://doi.org/10.1111/j.1440-1819.1992.tb00821.x

I could not find any source regarding the treatment of TS-proper with biperiden. Sappygang (talk) 12:33, 5 April 2024 (UTC)[reply]

Can anybody help clarify following

"Biperiden is no longer marketed in the United States." Is this statement correct? if so, the reason? Thank you for your kind attention. ThomasYehYeh (talk) 13:51, 5 May 2024 (UTC)[reply]